SINO LION VENTURES Ltd
CIK: 0002120638
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INDP
Indaptus Therapeutics, Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About SINO LION VENTURES Ltd
SINO LION VENTURES Ltd (SEC CIK 0002120638) files insider reports with the SEC as 10% Owner of Indaptus Therapeutics, Inc. (INDP).
Signal8 holds 1 ownership filing by SINO LION VENTURES Ltd, a Form 3, filed on Apr 2, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on SINO LION VENTURES Ltd's filings is in NEW YORK, NY.
Other insiders filing for Indaptus Therapeutics, Inc. (INDP)
- Lu Qinglai, Director
- Yao Yun, 10% Owner
- Dai Junyi, Chief Executive Officer
- Lazar David E., Director
- Jabbour Jerome D, Director
- McMurdo Matthew Charles, Director